Farm Animal Healthcare Market by Products (vaccines, paraciticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), By diagnostic technologies, by Animal Type

Cattle producers have long recognized the need for proper husbandry and stewardship, given the intensive animal husbandry model that currently houses a majority of cattle reared each year. Growing beef production and increasing demand for animal protein in an era of ever stricter regulations for rearing and food safety testing will have a positive impact on the cattle healthcare market. Health consciousness is an increasing concern and as Americans attempt to eat healthier food, producers respond and new products are appearing in the marketplace - and beef is no exception.

Statistics shows that in 2013, global cattle population was estimated to be 1485.2 million and with increasing awareness for cattle healthcare, number is expected to increase further which in turn will propel cattle healthcare market to grow.

In a country wise analysis it is seen that emerging markets such as Eastern Europe, Latin America and Asia are witnessing an increase in share because of the increasing importance given to animal health by the livestock breeders. As these regions are showing very strong economic growth in recent past years, livestock breeders are giving due importance to management of cattle health to cater to the growing nutritional needs of population. In developed countries market will be stagnant in coming years because of less consumption of cattle meat and dairy products.

Major company players are looking at the entire cattle healthcare ecosystem to maximize value for farmers. Creating value in addition to the products and services that firms offer has been a key strategy. The E=P+S program, for instance, helps farmers become profitable while keeping their operations sustainable given more discriminating preferences of end-consumers.

In this report, the market is segmented by type of disease into vaccines, Paraciticides, Anti-Infectives; Medicinal feed additives, and other pharmaceuticals. The market is further segmented by diagnostics -Enzyme Linked Sorbent Assay (ELISA), Rapid Immuno migration (RIM), and Agar Gel Immuno diffusion (AGID), and genetics. Regional markets analyzed in this report are North America, Europe, Asia-Pacific and the rest ofthe world (Row).

What the report offers

1) Market definition for Global cattle healthcare with information on drivers and restraints.

2) Market Analysis involving Cattle healthcare products available in market, relation between animal medicines and human medicines.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape with profiles of major companies along with their market share.

5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for buying this report

1) We provide you the longest market segmentation by type of products (vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals), By Diagnostic market, by Genetics market and by Geography.

2)Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.

3)Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.

Management of livestock to cater to the growing nutritional needs of populations. But with various kinds of diseases reducing global animal production, animal healthcare is gaining significant importance. Emerging economies thus offer significant potential for animal health industry in the near future.

The mature markets of North America and Western Europe, however, are supporting the growth of animal health market as these regions are characterized by strong growth, particularly in the companion animals sector.


1.1 Market Definition

1.2 Market Recent Trends

2. Market Analysis

2.1 Market Animal Health Products

2.2 Animal medicines vs human Medicines

3. Market Dynamics

3.1 Market Drivers

3.1.1 Increase in pet ownership

3.1.2 Improved Nutrition

3.1.3 Intensifying consumer focus on food safety

3.1.4 Greater Livestock production

3.1.5 Increasing Zoonotic and Foodborne Diseases

3.2 Market Constraints

3.2.1 Scarcity of arable land and water

3.2.2 Increased competition for cultivated land

3.2.3 Cost effective production

3.3 Porter's Five Force Analysis

3.3.1 Threat of New Entrant

3.3.2 Internal Rivalry

3.3.3 Buyer bargaining power

3.3.4 Supplier bargaining power

3.3.5 Threat of substitutes

4 Global Farm Animal Market Segmentation -By products

4.1 Farm Animals

4.1.1 Vaccines

4.1.2 Paraciticides

4.1.3 Anti-Infectives

4.1.4 Medicinal Feed additives

4.1.5 Other Pharmaceuticals

4.2 Farm animal


4.2.2 Swine

4.2.3 Poultry

4.2.4 Fish

4.2.5 Sheep

5 Global Farm Animal Diagnostics Market

5.1.1 Enzyme Linked Immuno Sorbent Assay( ELISA)

5.1.2 Rapid Immuno Migration( RIM)

5.1.3 Agar gel Immuno Diffusion( AGID)

6. Global Farm Animal Genetics Market

6.1 HD 50K for Angus

6.2 CLARIFIDE ? for Dairy

6.3 Sheep 50K

6.4 CLARIFIDE ? for Nelore

6.5 Others

7.Global Farm Animal Market Segmentation, By Geography

7.1 North America

7.1.1 US

7.1.2 Mexico


7.2 Europe

7.2.1 France

7.2.2 Italy

7.2.3 Germany

7.2.4 Spain

7.2.5 Italy

7.3 Asia-Pacific


7.3.2 China

7.3.3 Japan

8. Competitive landscape

8.1 Major players in the market

8.2 Mergers and acquisitions

8.3 New product launches

8.4 Agreement, Collaborations and Partnerships

8.5 Recommendations for New market players

8.6 Recommendations for Existing market players

8.7 Market Share Analysis

9.Company profiles

9.1 Zoetis animal healthcare

9.1.1 Financial Overview

9.1.2 Business overview

9.1.3 Business strategies

9.2 Merck

9.2.1Financial Overview

9.2.2 Business overview

9.2.3 Business strategies

9.3 Merial (Animal Health Division Of Sanofi)

9.3.1 Financial Overview

9.3.2 Business overview

9.3.3 Business strategies

9.4 Elanco

9.4.1Financial Overview

9.4.2 Business overview

9.4.3 Business strategies

9.5 Bayer healthcare

9.5.1 Financial Overview

9.5.2 Business overview

9.5.3 Business strategies

9.6 Novartis Animal Health, Inc.

9.6.1 Financial Overview

9.6.2 Business overview

9.6.3 Business strategies

9.7 Virbac

9.7.1 Financial Overview

9.7.2 Business overview

9.7.3 Business strategies

9.8 Boehringer Ingelheim

9.8.1 Financial Overview

9.8.2 Business overview

9.8.3 Business strategies

10. Appendix

10.1. Abbreviations

10.2. Sources

10.3. Bibliography

10.4. Disclaimer

Content are not available

Choose License Type